Author’s reply: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis (Br J Surg 2020; 107: 1811-1817) | Zendy

AI Assistant Blog Pricing

Author’s reply: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis (Br J Surg 2020; 107: 1811-1817)

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.